BRCA2 and neoplasm: The offset- and the calibration-analyses indicated that especially the tumor grade appeared to confuse the PREDICT ER-positive score, when predicting the BRCA2 variant carrier survival, whereas the factors related to the stage of malignant progression, like tumor size and node involvement, retained their predictive potential.